Viatris Pharma GmbH - Posaconazol Viatris 40 mg/ml, Suspension zum Einnehmen | | 68271 | | 01 | | Posaconazol Viatris 40 mg/ml | | Suspension zum Einnehmen | | J02AC04 | | Posaconazole | | 19.07.2021 | | |
| Composition | posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, E 171, aromatica (Kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg. | Packungsbestandteile | | Suspension (oral) | | | | | | Active Agent | Dose |
---|
Posaconazole | 200mg / 5ml |
| BAG: Active Agent | Dose |
---|
Posaconazole | 200 mg |
| | Inactive agents | Dose | additional_information |
---|
Citric Acid Monohydrate | | | Acidum Sorbicum | | | Aromatica (Kirschen) | | | E 171 | | color. | Glucosum Liquidum | 2108.5mg / 5ml | | Glycerol | | | Methylcellulosum | | | Sodium Benzoate | 10mg / 5ml | | Natrii Dihydrogenocitras Anhydricus | | | Natrii Laurilsulfas | | | Simeticone | | | Xanthani Gummi | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 105 ml | 513.14 | 574.50 | B | SL | No |
|
|